IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. 
Trial of Chemoradiation and Pembrolizumab in Patients With Rectal Cancer
This study has been withdrawn prior to enrollment.
(Dr. Rahma decided to run the study through a different group)
Sponsor:
Osama Rahma, MD
Collaborators:
Hoosier Cancer Research Network
Merck Sharp & Dohme Corp.
Information provided by (Responsible Party):
Osama Rahma, MD, Hoosier Cancer Research Network
ClinicalTrials.gov Identifier:
NCT02586610
First received: October 22, 2015
Last updated: January 18, 2017
Last verified: January 2017
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
Study was withdrawn before participants were enrolled.
| Study Status: | This study has been withdrawn prior to enrollment. |
|---|---|
| Estimated Study Completion Date: | December 2020 |
| Estimated Primary Completion Date: | June 2018 (Final data collection date for primary outcome measure) |